Home › Prostate Cancer › Montana › Great Falls
Prostate Cancer clinical trials in Great Falls, MT
10 studies for Prostate Cancer are looking for participants at sites in and around Great Falls (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Benefis Sletten Cancer Institute, Great Falls
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RecruitingPhase 2
- Benefis Healthcare- Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Benefis Healthcare- Sletten Cancer Institute, Great Falls
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Great Falls
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer9 studies
- Acute Myeloid Leukemia6 studies
- Colorectal Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Melanoma5 studies
- Breast Cancer5 studies
- Bladder Cancer5 studies
- Colon Cancer4 studies
- Endometrial Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Hypopharyngeal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.